Stomach Cancer Trial, Recruiting NCT04907643 Sponsor: Cedars-Sinai Medical Center Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04907643
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a cancer that started in the bile ducts, colon, liver, pancreas, peritoneum (lining of the abdomen), rectum, small intestine, or stomach, and there are no plans to surgically remove the tumor during the study
  • Your cancer can be one of several types, including adenocarcinoma, squamous cell carcinoma, neuroendocrine tumors, or tumors from connective tissue (confirm with trial site if unsure about your specific type)
  • You have significant stomach or abdominal pain related to your cancer, measured by a standard pain questionnaire called the NIH PROMIS GI Pain Scale, with a score at least 5 points above the national average
  • You are able to read and write in English

Who may not be able to join:

  • You have a condition that would make it unsafe or impossible to use a Virtual Reality (VR) headset, such as a history of seizures, an injury to your face, or significant vision problems
  • You have a level of cognitive (thinking or memory) difficulty that would prevent you from fully taking part in the study — this will be checked during an initial phone call
  • Your cancer has spread to your brain
  • Your doctor estimates your life expectancy to be less than 3 months at the time of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Brennan Spiegel, MD, MSHS, Cedars-Sinai Medical Center

Phone: 3104236721

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
5 October 2021
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient-Reported Outcomes Measurement Information System Gastrointestinal Belly Pain over 30 days from the baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov